Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Pennant Group
PNTG
$1.36B
| $2.13M | ﹤0.01% |
75,704
+8,095
| +12% | +$265K |
|
2002
SiriusPoint
SPNT
$2.68B
| $2.12M | ﹤0.01% |
228,879
+35,984
| +19% | +$345K |
|
2003
Clearway Energy Class C
CWEN
$6.7B
| $2.12M | ﹤0.01% |
69,909
+7,819
| +13% | +$233K |
|
2004
Interface
TILE
$2.22B
| $2.11M | ﹤0.01% |
138,977
+11,709
| +9% | +$168K |
|
|
FLNA
2005
Filana Therapeutics
FLNA
$48.1M
| $2.1M | ﹤0.01% |
33,795
+24,849
| +278% | +$2.07M |
|
|
AVTA
2006
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.1M | ﹤0.01% |
134,507
+10,684
| +9% | +$173K |
|
2007
First Advantage
FA
$4.12B
| $2.09M | ﹤0.01% |
109,759
+27,759
| +34% | +$583K |
|
2008
Helios Technologies
HLIO
$2.76B
| $2.09M | ﹤0.01% |
25,456
+5,960
| +31% | +$486K |
|
2009
Artivion
AORT
$1.32B
| $2.08M | ﹤0.01% |
93,260
-78,744
| -46% | -$2.03M |
|
|
NARI
2010
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $2.08M | ﹤0.01% |
25,624
+3,807
| +17% | +$320K |
|
|
HSII
2011
DELISTED
Heidrick & Struggles
HSII
| $2.07M | ﹤0.01% |
46,326
+3,985
| +9% | +$168K |
|
|
MNTV
2012
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $2.07M | ﹤0.01% |
105,463
+26,571
| +34% | +$540K |
|
2013
Magnolia Oil & Gas
MGY
$5.94B
| $2.06M | ﹤0.01% |
115,764
+27,506
| +31% | +$416K |
|
|
DCT
2014
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $2.06M | ﹤0.01% |
46,580
+7,405
| +19% | +$335K |
|
2015
Newmark Group
NMRK
$2.63B
| $2.04M | ﹤0.01% |
142,418
+33,795
| +31% | +$436K |
|
|
FSR
2016
DELISTED
Fisker Inc.
FSR
| $2.04M | ﹤0.01% |
139,065
+98,294
| +241% | +$1.48M |
|
2017
Harmonic Inc
HLIT
$1.28B
| $2.02M | ﹤0.01% |
231,310
+21,634
| +10% | +$194K |
|
|
MCHB
2018
Mechanics Bancorp
MCHB
$3.68B
| $2.02M | ﹤0.01% |
49,205
+3,416
| +7% | +$133K |
|
2019
Sotera Health
SHC
$5.38B
| $2.02M | ﹤0.01% |
77,167
+30,364
| +65% | +$735K |
|
2020
Photronics
PLAB
$1.93B
| $2.02M | ﹤0.01% |
147,938
+10,093
| +7% | +$137K |
|
2021
Live Oak Bancshares
LOB
$1.97B
| $2.01M | ﹤0.01% |
31,622
+20,050
| +173% | +$1.19M |
|
2022
Monarch Casino & Resort
MCRI
$2.23B
| $2.01M | ﹤0.01% |
30,043
+2,790
| +10% | +$180K |
|
2023
Array Technologies
ARRY
$855M
| $2.01M | ﹤0.01% |
108,424
+22,523
| +26% | +$374K |
|
2024
InMode
INMD
$880M
| $2.01M | ﹤0.01% |
25,160
+22,352
| +796% | +$1.36M |
|
2025
PennyMac Financial
PFSI
$4.02B
| $2M | ﹤0.01% |
32,711
+10,418
| +47% | +$662K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.